Recent Advances and Future Directions in Bone Marrow Transplantation

I. Experimental Bone Marrow Transplantation.- 1 Graft-versus-Host Disease and Graft-versus-Leukemia in Experimental Systems.- 2 Syngeneic Graft-versus-Host Disease: Failure of Self: Non-Self Discrimination.- 3 Transfusion-Induced Allosensitization in Marrow Transplant Recipients: Mechanisms and Preventive Measures.- II. Experimental Bone Marrow Transplantation.- 4 Utilization of Monoclonal Antibodies for Autologous Bone Marrow Transplantation.- 5 Characterization of Malignant Lymphoma in Dogs and Use as a Model for the Development of Treatment Strategies.- 6 Hematopoietic Cell Transplantation in Murine Globoid Cell Leukodystrophy (The Twitcher Mouse)—A Model of a Human Sphingolipidosis (Krabbe Disease).- 7 Experimental Basis of Bone Marrow Purging with Chemical and Photodynamic Agents.- III. Leukemia.- 8 Oncogenes in Acute Myelogenous Leukemia.- 9 Optimal Timing of Marrow Transplantation for Patients with Acute Nonlymphoblastic and Acute Lymphoblastic Leukemia.- 10 Perspectives in Treatment of Adult Leukemia with High Dose Cytoreductive Therapy and Autologous Bone Marrow Treated Ex Vivo.- IV. Autologous and Allogeneic Marrow Transplants in Leukemia and Lymphoma (Session A).- 11 Allogeneic and Autologous Marrow Transplants in Acute Nonlymphoblastic Leukemia (ANLL).- 12 Allogeneic Transplantation for Acute Lymphoblastic Leukemia.- 13 Autologous Bone Marrow Transplantation in Acute Lymphoblastic Leukemia—Mafosfamide Italian Study Group.- 14 Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia.- V. Autologous and Allogeneic Marrow Transplants in Leukemia and Lymphoma (Session B).- 15 Autologous Marrow Transplantation for Hodgkin’s and Non-Hodgkin’s Lymphoma: Preliminary Results Using New Conditioning Regimens.- 16 Long-Term Bone Marrow Culture inAutologous Transplantation: An In Vitro Biological System for Purging Leukemic Cells.- 17 Allogeneic Bone Marrow Transplantation for Leukemia—Japanese Experience.- VI. Aplastic Anemia.- 18 Allogeneic and Syngeneic Marrow Transplantation for Aplastic Anemia: Overview of Seattle Results.- 19 Recent Advances and Future Trends in Bone Marrow Transplantation for Severe Aplastic Anemia.- 20 Allogeneic Bone Marrow Transplantation in Leukemia.- VII. Acute Graft-versus-Host Disease.- 21 Bone Marrow Transplantation: The Difficulties Ahead.- 22 Predictive Models of Graft-versus-Host Disease.- 23 Prevention of Severe GVHD Employing Cyclosporine in HLA-Matched Marrow Transplant for Leukemia.- VIII. Chronic Graft-versus-Host Disease.- 24 Chronic Graft-versus-Host Disease: Pathogenesis, Diagnosis, Treatment and Prognostic Factors.- 25 The Role of Autoreactive T Lymphocytes in Graft-versus-Host Disease (GVHD).- 26 Predictive Factors for Chronic Graft-versus-Host Disease and Leukemic Relapse After Allogeneic Bone Marrow Transplantation.- IX. Infections After Bone Marrow Transplants.- 27 Viral Infection Following Bone Marrow Transplantation.- 28 Bacterial, Fungal, and Protozoan Infection After Marrow Transplantation.- 29 Prevention and Treatment of Infections after Bone Marrow Transplantation.- X. Metabolic and Genetic Disorders.- 30 Bone Marrow Transplantation for Thalassemia: 156 Cases Transplanted in Pesaro.- 31 Improvement of Clinical Expression of Central Nervous System Manifestation in Lysosomal Storage Diseases Treated By Bone Marrow Transplantation.- 32 Bone Marrow Transplantation Following Nuclear Accidents.- Conclusions.